Adaptive hybrid surgery analysis (AHSA) for adjuvant gamma knife radiosurgery treatment of vestibular schwannoma residuals.

OBJECTIVES: Adaptive Hybrid Surgery Analysis (AHSA, Brainlab, Munich, Germany) is a software application generating in real-time conceptual dose plans for tumor residuals but has so far not been assessed for usability in a Gamma Knife (Elekta, Stockholm, Sweden) radiosurgery practice. We aimed to compare AHSA stereotactic radiosurgery dose plans with Leksell Gamma Plan (LGP, Elekta, Stockholm, Sweden) plans for adjuvant radiosurgical treatment of Vestibular Schwannoma (VS) residuals. PATIENTS AND METHODS: In this retrospective comparative study, we compared the automatically calculated AHSA dose plans with clinical LGP treatment plans in 13 patients radiosurgically treated for VS residuals. We first created an LGP template based on our specific constraints to organs at risk (OAR), and a tumor prescription volume coverage of minimum 98%. As most proximal anatomy at risk is not manually contoured in our practice, OARs (i.e. brainstem, optic apparatus and cochlea) in the planning images were automatically segmented in Elements Anatomical Mapping and imported into the AHSA software for re-planning and comparison with the LGP dose plans. RESULTS: There was no significant difference in tumor coverage and conformity index between the LGP and AHSA dose planning data, with the mean and maximal dose to the brainstem slightly higher in the latter. CONCLUSION: The AHSA dose plans for adjuvant radiosurgical treatment of VS residuals were comparable to those of LGP used in our Gamma Knife practice, confirming the usability of AHSA in the management of Vestibular Schwannoma in a Gamma Knife practice.

Dorsally Displaced Facial Nerve in Retrosigmoid Transmeatal Approach for Vestibular Schwannoma: 3-Dimensional Operative Video.

Dorsal displacement of the facial nerve is relatively rare in patients with vestibular schwannoma. Its prediction remains difficult in patients with large tumors, even with the recent advances in preoperative radiologic assessments. Anatomic and functional preservation of the facial nerves combined with maximal tumor removal is particularly challenging in this rare anatomic variant, and surgery may lead to postoperative facial dysfunction, inadequate tumor removal, and/or a high retreatment rate.1 This 3-dimensional video (Video 1) demonstrates a vestibular schwannoma with dorsally displaced facial nerve, which was surgically treated by the retrosigmoid transmeatal approach under continuous facial nerve monitoring. The video was reproduced after informed consent of the patient. A 46-year-old man presented with transient hearing impairment. Neuroimaging displayed a left acoustic tumor extending into the internal acoustic meatus. The retrosigmoid transmeatal approach was performed, and a dorsally displaced facial nerve was predicted by preoperative magnetic resonance images and confirmed during surgery. The facial nerve was accurately dissected under continuous facial nerve monitoring, and gross total removal of the tumor was achieved without postoperative facial dysfunction.2.

Facial preservation following extreme mummification: Shrunken heads.

Shrunken heads are a mummification phenomenon unique to South America. Ceremonial tsantsa are ritually reduced heads from enemy victims of the Shuar, Achuar, Awajún (Aguaruna), Wampís (Huambisa), and Candoshi-Shapra cultures. Commercial shrunken heads are comparatively modern and fraudulently produced for the curio-market, often using stolen bodies from hospital mortuaries and graves. To achieve shrinkage and desiccation, heads undergo skinning, simmering (in water) and drying. Considering the intensive treatments applied, this research aims to identify how the facial structure can alter and impact identification using post-mortem depiction. Sixty-five human shrunken heads were assessed: 6 ceremonial, 36 commercial, and 23 ambiguous. Investigations included manual inspection, multi-detector computerised tomography, infrared reflectography, ultraviolet fluorescence and microscopic hair analysis. The mummification process disfigures the outer face, cheeks, nasal root and bridge form, including brow ridge, eyes, ears, mouth, and nose projection. Melanin depletion, epidermal degeneration, and any applied staining changes the natural skin complexion. Papillary and reticular dermis separation is possible. Normal hair structure (cuticle, cortex, medulla) is retained. Hair appears longer (unless cut) and more profuse following shrinkage. Significant features retained include skin defects, facial creases, hairlines and earlobe form. Hair conditions that only affect living scalps are preserved (e.g. nits, hair casts). Ear and nose cartilage helps to retain some morphological information. Commercial heads appear less distorted than ceremonial tsantsa, often presenting a definable eyebrow shape, vermillion lip shape, lip thickness (if mouth is open), philtrum form, and palpebral slit angle. Facial identification capabilities are considered limited, and only perceived possible for commercial heads.

Fractionated radiation therapy for vestibular schwannoma.

Vestibular schwannomas are the most common tumors of the cerebellopontine angle. Multiple management paradigms exist for patients with these benign tumors, including observation, microsurgery, stereotactic radiosurgery, and fractionated radiation therapy, or some combination of these. While the proper course of management is controversial, the goals of therapy are to achieve excellent local tumor control and optimize functional outcomes with as little treatment-related morbidity as possible. Decision-making is tailored to patient-specific factors such as tumor size, clinical presentation, patient age, and goals of hearing preservation. We review the literature in order to summarize the application of fractionated radiation therapy to this tumor entity, where it is used as a primary treatment or, more commonly, as an adjunct therapy. We also provide an overview of the use of fractionated radiation therapy for the preservation of hearing and facial function, and dosing and other technical considerations, in light of the indolent natural history of vestibular schwannomas. We also discuss potential risks associated with this treatment modality, including its effects on temporal bone structures and cranial nerves among other possible complications. Lastly, we outline future directions in this rapidly evolving segment of vestibular schwannoma therapy, which has benefited from the advent of intensity-modulated radiation therapy coupled with stereotactic localization.

Vascular leiomyoma and geniculate ganglion.

Objectives Discussion of a rare case of angioleiomyoma involving the geniculate ganglion and the intratemporal facial nerve segment and its surgical treatment. Design Case report. Setting Presence of an expansive lesion englobing the geniculate ganglion without any lesion to the cerebellopontine angle. Participants A 45-year-old man with a grade III facial paralysis according to the House-Brackmann scale of evaluation. Main Outcomes Measure Surgical pathology, radiologic appearance, histological features, and postoperative facial function. Results Removal of the entire lesion was achieved, preserving the anatomic integrity of the nerve; no nerve graft was necessary. Postoperative histology and immunohistochemical studies revealed features indicative of solid vascular leiomyoma. Conclusion Angioleiomyoma should be considered in the differential diagnosis of geniculate ganglion lesions. Optimal postoperative facial function is possible only by preserving the anatomical and functional integrity of the facial nerve.

Schwannomas vestibulares quísticos / Cystic vetibular schwannomas

Objetivo. Presentar nuestra experiencia en el tratamiento de los Schwannomas vestibulares quísticos comparándolos con lesiones sólidas. Material y método. Se evaluaron en forma retrospectiva los síntomas de presentación clínica, tasas de preservación facial, grado de resección quirúrgica, complicaciones postoperatorias y hallazgos histológicos de los Schwannomas quísticos pareados en base al tamaño tumoral con un grupo de lesiones sólidas. Resultados. Durante el período junio 1995 julio 2010, 27 pacientes con Schwannomas quísticos se operaron en nuestro Departamento. El diámetro promedio fue de 29,6 mm. Los síntomas de presentación clínica más frecuentes fueron la hipoacusia, inestabilidad en la marcha y parestesias faciales. Al año de cirugía, el 74% de los pacientes tenían función facial HB I-III sin diferencias significativas con el grupo de lesiones sólidas. La remoción completa fue 55,5% y 85% de los pacientes en las lesiones quísticas ysólidas respectivamente. Conclusión. Los Schwannomas quísticos deben ser evaluados en forma separada de las lesiones sólidas debido a que pueden crecer rápidamente, presentar mayor complejidad quirúrgica y desarrollar complicaciones postoperatorias con mayor frecuencia.

Objective. To present our experience treating this rare tumor variant.Material and Method. Retrospective evaluation of an institutional cystic vestibular schwannoma series, based on initial symptoms, rate of facial preservation, extent of surgical resection, postoperative complication rate and cystic lesion quantificationon histology in comparison to solid tumor type. Results. During the period June 1995-July 2010, 27 cysticschwannomas were operated on at the FLENI neurological Institute. Mean tumor diameter was 29,6mm. The most frequent presenting symptoms included hypoacusia, unsteadiness and facial paresthesias. One year after surgery, 74% of patients presented facial function HB I-III, showing no statistical difference in comparison to solid lesions. Complete surgical resectionwas possible in 55, 5% of the cystic and 85% of the solid tumor groups, respectively. Conclusion. Cystic vestibular schwannomas should be identified separately from vestibular schwannomas in general, particularlybecause they often undergo more rapid expansion, and may present greater surgical risk as well as higher rates ofpostoperative complications.

Schwannomas vestibulares quísticos / Cystic vetibular schwannomas

Objetivo. Presentar nuestra experiencia en el tratamiento de los Schwannomas vestibulares quísticos comparándolos con lesiones sólidas. Material y método. Se evaluaron en forma retrospectiva los síntomas de presentación clínica, tasas de preservación facial, grado de resección quirúrgica, complicaciones postoperatorias y hallazgos histológicos de los Schwannomas quísticos pareados en base al tamaño tumoral con un grupo de lesiones sólidas. Resultados. Durante el período junio 1995 julio 2010, 27 pacientes con Schwannomas quísticos se operaron en nuestro Departamento. El diámetro promedio fue de 29,6 mm. Los síntomas de presentación clínica más frecuentes fueron la hipoacusia, inestabilidad en la marcha y parestesias faciales. Al año de cirugía, el 74% de los pacientes tenían función facial HB I-III sin diferencias significativas con el grupo de lesiones sólidas. La remoción completa fue 55,5% y 85% de los pacientes en las lesiones quísticas ysólidas respectivamente. Conclusión. Los Schwannomas quísticos deben ser evaluados en forma separada de las lesiones sólidas debido a que pueden crecer rápidamente, presentar mayor complejidad quirúrgica y desarrollar complicaciones postoperatorias con mayor frecuencia.(AU)

Objective. To present our experience treating this rare tumor variant.Material and Method. Retrospective evaluation of an institutional cystic vestibular schwannoma series, based on initial symptoms, rate of facial preservation, extent of surgical resection, postoperative complication rate and cystic lesion quantificationon histology in comparison to solid tumor type. Results. During the period June 1995-July 2010, 27 cysticschwannomas were operated on at the FLENI neurological Institute. Mean tumor diameter was 29,6mm. The most frequent presenting symptoms included hypoacusia, unsteadiness and facial paresthesias. One year after surgery, 74% of patients presented facial function HB I-III, showing no statistical difference in comparison to solid lesions. Complete surgical resectionwas possible in 55, 5% of the cystic and 85% of the solid tumor groups, respectively. Conclusion. Cystic vestibular schwannomas should be identified separately from vestibular schwannomas in general, particularlybecause they often undergo more rapid expansion, and may present greater surgical risk as well as higher rates ofpostoperative complications.(AU)